Amedes brings lenders back to the table with wider pricing
Belgian and German medical diagnostics provider Amedes brought some investors who had initially declined the €525m loan back into the fold this week as deal supply fell.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts